Company Filing History:
Years Active: 2024-2025
Title: Ian Holmes - Innovator in Respiratory Health
Introduction
Ian Holmes is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of respiratory health through his innovative research and development of TLR2 agonist compounds. With a total of 2 patents, his work focuses on the prevention and treatment of respiratory infections.
Latest Patents
Holmes' latest patents include groundbreaking inventions related to TLR2 agonist compounds. The first patent, titled "Optimised Compounds," pertains to the use of these compounds and their compositions in preventing and treating respiratory infections, as well as diseases associated with viral or bacterial infections. The second patent, simply titled "Molecules," shares a similar focus, emphasizing the importance of TLR2 agonist compounds in combating respiratory health issues.
Career Highlights
Throughout his career, Ian Holmes has worked with several prominent companies, including Axelia Oncology Pty Ltd and Ena Respiratory Pty Ltd. His experience in these organizations has allowed him to further his research and contribute to advancements in respiratory health.
Collaborations
Holmes has collaborated with notable professionals in his field, including Christophe Demaison and David Jackson. These partnerships have enhanced his research efforts and expanded the impact of his inventions.
Conclusion
Ian Holmes is a dedicated inventor whose work in respiratory health has led to significant advancements in the treatment of infections. His innovative patents and collaborations reflect his commitment to improving health outcomes for individuals affected by respiratory diseases.